Nucleocytoplasmic shuttling:: a novel in vivo property of antisense phosphorothioate oligodeoxynucleotides

被引:84
|
作者
Lorenz, P
Misteli, T
Baker, BF
Bennett, CF
Spector, DL
机构
[1] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA
[2] ISIS Pharmaceut, Carlsbad, CA 92008 USA
关键词
D O I
10.1093/nar/28.2.582
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Phosphorothioate oligodeoxynucleotides (P=S ODNs) are frequently used as antisense agents to specifically interfere with the expression of cellular target genes, However, the cell biological properties of P=S ODNs are poorly understood. Here we show that P=S ODNs were able to continuously shuttle between the nucleus and the cytoplasm and that shuttling P=S ODNs retained their ability to act as antisense agents. The shuttling process shares characteristics with active transport since it was inhibited by chilling and ATP depletion in vivo. Transport was carrier-mediated as it was saturable, and nuclear pore complex-mediated as it was sensitive to treatment with wheatgerm agglutinin, Oligonucleotides without a P=S backbone chemistry were only weakly restricted in their migration by chilling, ATP depletion and wheatgerm agglutinin and thus moved by diffusion. P=S ODN shuttling was only moderately affected by disruption of the Ran/RCC1 system. We propose that P=S ODNs shuttle through their binding to yet unidentified cellular molecules that undergo nucleocytoplasmic transport via a pathway that is not as strongly dependent on the Ran/RCC1 system as nuclear export signal-mediated protein export, U-snRNA, tRNA and mRNA export. The shuttling property of P=S ODNs must be taken into account when considering the mode and site of action of these antisense agents.
引用
收藏
页码:582 / 592
页数:11
相关论文
共 50 条
  • [1] Phosphorothioate antisense oligodeoxynucleotides: Questions of specificity
    Stein, CA
    TRENDS IN BIOTECHNOLOGY, 1996, 14 (05) : 147 - 149
  • [2] Exploiting the potential of antisense: Beyond phosphorothioate oligodeoxynucleotides
    Stein, CA
    CHEMISTRY & BIOLOGY, 1996, 3 (05): : 319 - 323
  • [3] PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES - ANTISENSE OR ANTI-PROTEIN
    KRIEG, AM
    STEIN, CA
    ANTISENSE RESEARCH AND DEVELOPMENT, 1995, 5 (04): : 241 - 241
  • [4] Antisense therapeutics: Beyond phosphorothioate oligodeoxynucleotides.
    Agrawal, S
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 217 : U221 - U221
  • [5] PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES - ANTISENSE INHIBITORS OF GENE-EXPRESSION
    STEIN, CA
    TONKINSON, JL
    YAKUBOV, L
    PHARMACOLOGY & THERAPEUTICS, 1991, 52 (03) : 365 - 384
  • [6] In vivo fate of phosphorothioate antisense oligodeoxynucleotides: Predominant uptake by scavenger receptors on endothelial liver cells
    Bijsterbosch, MK
    Manoharan, M
    Rump, ET
    DeVrueh, RLA
    vanVeghel, R
    Tivel, KL
    Biessen, EAL
    Bennett, CF
    Cook, PD
    vanBerkel, TJC
    NUCLEIC ACIDS RESEARCH, 1997, 25 (16) : 3290 - 3296
  • [7] Separation of Phosphodiester Oligodeoxynucleotides and Phosphorothioate Antisense Oligodeoxynucleotides by Capillary Zone Electrophoresis at Low pH
    Li Qian
    Chen Rong
    Sun Yuqing
    Hu Yuzhu
    CHINESE JOURNAL OF CHROMATOGRAPHY, 2007, 25 (01) : 101 - 106
  • [8] In vivo inhibition of hepatitis B virus replication and gene expression by targeted phosphorothioate modified antisense oligodeoxynucleotides
    钟森
    郑素军
    陈枫
    张建军
    邓存良
    温守明
    王升启
    中华肝脏病杂志, 2002, (04) : 44 - 47
  • [9] In vivo inhibition of hepatitis B viral gene expression by antisense phosphorothioate oligodeoxynucleotides in athymic nude mice
    Yao, ZQ
    Zhou, YX
    Feng, XM
    Chen, CX
    Guo, J
    JOURNAL OF VIRAL HEPATITIS, 1996, 3 (01) : 19 - 22
  • [10] The influence of phosphorothioate oligodeoxynucleotides on various organs in vivo
    NieborowskaSkorska, M
    Bialek, AP
    Nicolaides, NC
    Iozzo, RV
    Kawalec, M
    Calabretta, B
    Kawiak, J
    Marlicz, K
    Skorski, T
    FOLIA HISTOCHEMICA ET CYTOBIOLOGICA, 1996, 34 (02): : 69 - 73